Cofactor engineering: a novel approach to metabolic engineering in Lactococcus lactis by controlled expression of NADH oxidase.
NADH oxidase-overproducing Lactococcus lactis strains were constructed by cloning the Streptococcus mutans nox-2 gene, which encodes the H2O-forming NADH oxidase, on the plasmid vector pNZ8020 under the control of the L. lactis nisA promoter. This engineered system allowed a nisin-controlled 150-fold overproduction of NADH oxidase at pH 7.0, resulting in decreased NADH/NAD ratios under aerobic conditions. Deliberate variations on NADH oxidase activity provoked a shift from homolactic to mixed-acid fermentation during aerobic glucose catabolism. The magnitude of this shift was directly dependent on the level of NADH oxidase overproduced. At an initial growth pH of 6.0, smaller amounts of nisin were required to optimize NADH oxidase overproduction, but maximum NADH oxidase activity was twofold lower than that found at pH 7.0. Nonetheless at the highest induction levels, levels of pyruvate flux redistribution were almost identical at both initial pH values. Pyruvate was mostly converted to acetoin or diacetyl via alpha-acetolactate synthase instead of lactate and was not converted to acetate due to flux limitation through pyruvate dehydrogenase. The activity of the overproduced NADH oxidase could be increased with exogenously added flavin adenine dinucleotide. Under these conditions, lactate production was completely absent. Lactate dehydrogenase remained active under all conditions, indicating that the observed metabolic effects were only due to removal of the reduced cofactor. These results indicate that the observed shift from homolactic to mixed-acid fermentation under aerobic conditions is mainly modulated by the level of NADH oxidation resulting in low NADH/NAD+ ratios in the cells.
Lopez de Felipe
F
F
Wageningen Centre for Food Sciences, NIZO Food Research, 6710 BA Ede, The Netherlands.
Kleerebezem
M
M
de Vos
W M
WM
Hugenholtz
J
J
D000093:Acetoin / Q000378:metabolism; D000332:Aerobiosis; D003001:Cloning, Molecular; D003931:Diacetyl / Q000378:metabolism; D005285:Fermentation; D005182:Flavin-Adenine Dinucleotide / Q000494:pharmacology; D015964:Gene Expression Regulation, Bacterial; D005818:Genetic Engineering / Q000379:methods; D005947:Glucose / Q000378:metabolism; D013294:Lactococcus lactis / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D009097:Multienzyme Complexes / Q000096:biosynthesis* / Q000235:genetics*; D009243:NAD / Q000378:metabolism*; D009247:NADH, NADPH Oxidoreductases / Q000096:biosynthesis* / Q000235:genetics*; D009561:Nisin / Q000494:pharmacology; D011401:Promoter Regions, Genetic; D011994:Recombinant Proteins / Q000096:biosynthesis; D013295:Streptococcus mutans / Q000235:genetics*
D009097:Multienzyme Complexes; D011994:Recombinant Proteins; D009243:NAD; D009561:Nisin; D005182:Flavin-Adenine Dinucleotide; D000093:Acetoin; C023107:NADH oxidase; D009247:NADH, NADPH Oxidoreductases; D005947:Glucose; D003931:Diacetyl